alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.1

CERTIFICATIONS

I, George Kadifa, certify that:

1.	I have reviewed this annual report on Form 10-K/A of
Corio, Inc.

2.	Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect
to the period covered by this report;

3.	Based on my knowledge, the
financial statements and other financial information included in this report,
fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods
presented in this report;

4.	The registrant's other certifying
officers and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-
15(e) for the registrant and have:

a)	Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this
report is being prepared;

b)	Evaluated the effectiveness of the registrant's
disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation; and

c)	Disclosed in this report any change in the registrant's
internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth fiscal quarter in the case
of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

5.	The registrant's other certifying officer(s) and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent
functions):

a)	All significant deficiencies and
material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the
registrant's ability to record, process, summarize and report financial
information; and

b)	Any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant's
internal control over financial reporting.

Date: June 3, 2004



|/s/   GEORGEKADIFA                                
|--------------------------------------------------
|George KadifaPresident and Chief Executive Officer

---
<PAGE>
                                                                  EXHIBIT: 10.49

                     PULITZER INC. STOCK OPTION CERTIFICATE

This Certificate represents an option ("Option") to purchase shares of common
stock of Pulitzer Inc. (the "Company") granted to you on 12/10/2003 under the
Pulitzer Inc. 2003 Incentive Plan (the "Plan"). The basic features of this
Option grant are indicated below (and are subject to correction by the Company
if and to the extent this Certificate does not accurately reflect the terms of
the Option grant). This Option is governed by the terms and conditions of the
official Plan document. To accept this Option and its terms, you must sign and
return one copy of this Certificate to Pulitzer Inc., 900 North Tucker
Boulevard, St. Louis, Missouri 63101, Attention: Mr. James V. Maloney. By
executing this certificate, you acknowledge receipt of the Plan document and the
Summary Description of the Plan.


        Name of Optionee:  Alan G. Silverglat

  Social Security Number:

              Grant Date:  December 10, 2003

        Number of Shares:  10,000

Exercise Price per Share:  $52.9200

        Vesting Schedule:  Subject to continuing employment or service with the
                           Company, 100% on December 31, 2009, unless and except
                           to the extent vesting is accelerated (a) in
                           accordance with the performance-based vesting
                           conditions described in Exhibit A (attached), as
                           construed and applied by the Compensation Committee
                           of the Board of Directors of the Company, or (b) upon
                           the occurrence of an event that would cause the
                           acceleration of vesting under the terms of the
                           Executive Transition Agreement dated as of January 1,
                           2002 between the Company and the Executive.

<TABLE>
<CAPTION>
                                 INCREMENTAL      AGGREGATE
                  DATE             VESTING         VESTING
                  ----           -----------      ---------
               <S>               <C>              <C>
               12/31/2009          10,000            10,000
</TABLE>

Termination of Employment: Death, disability, retirement after age 65 or with
                           Company consent--vesting accelerates; 3 years to
                           exercise

                           Other termination of employment-- forfeit non-vested
                           options; 60 days to exercise vested options

    Expiration of Option:  December 10, 2013--even if still employed or
                           post-termination exercise period (see above) is still
                           open

Accepted and Agreed to by:                      PULITZER INC.



Signature:                                      By:
           ---------------------                   -----------------------------
           Alan G. Silverglat                       James V. Maloney, Secretary
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
      ( print page 430)    
*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; SEP-1: NCI Clinical and Translational R21 and Omnibus R03.                    

*Date:*                         February 28-March 1, 2019.                    

*Time:*                         5:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.                    

*Contact Person:*                         Zhiqiang Zou, MD, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W242, Bethesda, MD 20892-9750, 240-276-6372                         *zouzhiq@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: January 18, 2019.

Melanie J. Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2019-00163 Filed 1-25-19; 8:45 am]

 BILLING CODE 4140-01-P
Home > NRC Library > ADAMS Public Documents

# Amendment No. 1 to Certificate Of Compliance No. 1030 for the NUHOMS HD System.

Accession Number: ML110890289

Date Released: Wednesday, March 30, 2011

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
    - ML110890302 - J. Bondre Letter re: Amendment No. 1 to Certificate of Compliance No. 1030 for the NUHOMS HD System. (5 page(s), 3/29/2011)
    - ML110890305 - Enclosure 1: Certificate of Compliance No. 1030, Amendment No. 1 (J. Bondre Letter re: Amendment No. 1 to Certificate Of Compliance No. 1030 for the NUHOMS HD System). (4 page(s), 3/29/2011)
    - ML110890313 - Appendix a to Certificate of Compliance No. 1030 - NUHOMS HD System Generic Technical Specifications (J. Bondre Letter re: Amendment No. 1 to Certificate of Compliance No. 1030 for the NUHOMS HD System). (55 page(s), 3/29/2011)
    - ML110890330 - Enclosure 2: Safety Evaluation Report (J. Bondre Letter re: Amendment No. 1 to Certificate of Compliance No. 1030 for the NUHOMS HD System). (41 page(s), 3/29/2011)

Privacy PolicySite Disclaimer
<PAGE>

EXHIBIT 32.1

      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Kevin DeVito, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of
my knowledge, the Quarterly Report of New Capital iWorks, Inc. on Form 10-QSB
for the quarterly period ended September 30, 2003 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that information contained in such Quarterly Report fairly presents in all
material respects the financial condition and results of operations of New
Capital iWorks, Inc..


                           BY:   /S/ KEVIN DEVITO
                                 --------------------------------------
                                 KEVIN DEVITO, CHIEF EXECUTIVE OFFICER



I, Kevin DeVito, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of
my knowledge, the Quarterly Report of New Capital iWorks, Inc. on Form 10-QSB
for the quarterly period ended September 30, 2003 fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that information contained in such Quarterly Report fairly presents in all
material respects the financial condition and results of operations of New
Capital iWorks, Inc..


                           BY:   /S/ KEVIN DEVITO
                                 -------------------------------------
                                 KEVIN DEVITO, CHIEF FINANCIAL OFFICER
§ 919.880 What factors may influence the debarring official during reconsideration? The debarring official may reduce or terminate your debarment based on— ( a ) Newly discovered material evidence;
( b ) A reversal of the conviction or civil judgment upon which your debarment was based;
( c ) A bona fide change in ownership or management;
( d ) Elimination of other causes for which the debarment was imposed; or
( e ) Other reasons the debarring official finds appropriate.
### §1973. Forfeiture

Any person guilty of mutiny, treason, spying, or desertion, or who, because of conscientious objections, refuses to perform service in the Armed Forces of the United States or refuses to wear the uniform of such force, shall forfeit all rights to Servicemembers' Group Life Insurance and Veterans' Group Life Insurance under this subchapter. No such insurance shall be payable for death inflicted as a lawful punishment for crime or for military or naval offense, except when inflicted by an enemy of the United States.

(Added Pub. L. 89–214, §1(a), Sept. 29, 1965, 79 Stat. 885, §773; renumbered §1973, Pub. L. 102–83, §5(a), Aug. 6, 1991, 105 Stat. 406; amended Pub. L. 104–275, title IV, §405(b)(1)(F), Oct. 9, 1996, 110 Stat. 3339; Pub. L. 110–389, title IV, §403(d), Oct. 10, 2008, 122 Stat. 4174.)

#### **Editorial Notes**

#### Amendments

2008—Pub. L. 110–389 inserted "and Veterans' Group Life Insurance" before "under this subchapter".

1996—Pub. L. 104–275 substituted "Servicemembers' Group" for "Servicemen's Group".

1991—Pub. L. 102–83 renumbered section 773 of this title as this section.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 2008 Amendment

Pub. L. 110–389, title IV, §403(e)(4), Oct. 10, 2008, 122 Stat. 4175, provided that: "The amendment made by subsection (d) [amending this section] shall apply with respect to any act of mutiny, treason, spying, or desertion committed on or after the date of the enactment of this Act [Oct. 10, 2008] for which a person is found guilty, or with respect to refusal because of conscientious objections to perform service in, or to wear the uniform of, the Armed Forces on or after the date of the enactment of this Act."
EXHIBIT 10.08

                                WEST CORPORATION

                                   MEMORANDUM

TO: NANCEE BERGER

FROM: WSTC COMP. COMMITTEE

DATE: DECEMBER 2, 2003

RE: 2004 COMPENSATION PLAN - EXHIBIT A

The compensation plan for 2004 while you are employed as Chief Operating Officer
for West Corporation is outlined below:

1.       Your base salary will be $500,000.00. Should you elect to voluntarily
         terminate your employment, you will be compensated for your services
         through the date of your actual termination per your Employment
         Agreement. This will be reviewed on an annual basis and revised, if
         necessary in accordance with the consumer price index.

5.       Effective January 1, 2004, you will be eligible to receive a
         performance bonus based on consolidated net income growth for West
         Corporation in 2004. Net income for each quarter will be compared to
         the same quarter in the previous year. Each $1M increase of Net Income
         from $87M to $102.8M will result in a $31,700 bonus. 75% of the
         quarterly bonus earned will be paid within thirty (30) days from the
         end of the quarter. 100% of the total bonus earned will be paid within
         thirty (30) days of the final determination of 2004 Net Income.

         Should Net Income exceed $102.8M for the year you will eligible to
         receive $39,600 for every $1M of Net Income above that threshold.

         Please note that if there is a negative year-to date profit calculation
         at the end of any quarter this will result in a "loss carry forward" to
         be applied to the next quarterly or year-to-date calculation.

6.       All Net Income objectives are based upon West Corporation operations
         and will not include net income derived from mergers or acquisitions
         unless specifically and individually approved by West Corporation's
         Compensation Committee.

<PAGE>

9.       The benefit plans, as referenced in Section 7(i), shall include
         insurance plans based upon eligibility pursuant to the plans. If the
         insurance plans do not provide for continued participation, the
         continuation of benefits shall be pursuant to COBRA. In the event
         Employee's benefits continue pursuant to COBRA and Employee accepts new
         employment during the consulting term, Employee may continue benefits
         thereafter to the extent allowed under COBRA. In no event shall
         benefits plans include the 401K Plan or the 1996 Stock Incentive Plan.

<PAGE>

INTEROFFICE MEMORANDUM
EXHIBIT A - N. BERGER
DECEMBER 2, 2003
PAGE TWO

10.      At the discretion of management, you may receive an additional bonus
         based on the Companies' and your individual performance.

6.       Your Compensation Plan for the year 2005 will be presented in December,
         2004.

                                   /s/ Nancee Berger
                                   --------------------
                                   EMPLOYEE - NANCEE BERGER
108TH CONGRESS 

2D SESSION H. R. 2391

AN ACT

To amend title 35, United States Code, to promote 

cooperative research involving universities, the public sector, and private enterprises. 

108TH CONGRESS 

2D SESSION H. R. 2391

AN ACT

To amend title 35, United States Code, to promote cooperative research involving universities, the public sector, and 

private enterprises.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2

•HR 2391 EH 

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Cooperative Research 

3 and Technology Enhancement (CREATE) Act of 2004’’. 

4 SEC. 2. COLLABORATIVE EFFORTS ON CLAIMED INVEN5 TIONS. 

6 Section 103(c) of title 35, United States Code, is 

7 amended to read as follows: 

8 ‘‘(c)(1) Subject matter developed by another person, 

9 which qualifies as prior art only under one or more of sub10 sections (e), (f), and (g) of section 102 of this title, shall 

11 not preclude patentability under this section where the 

12 subject matter and the claimed invention were, at the time 

13 the claimed invention was made, owned by the same per14 son or subject to an obligation of assignment to the same 

15 person. 

16 ‘‘(2) For purposes of this subsection, subject matter 

17 developed by another person and a claimed invention shall 

18 be deemed to have been owned by the same person or sub19 ject to an obligation of assignment to the same person if—

20 ‘‘(A) the claimed invention was made by or on 

21 behalf of parties to a joint research agreement that 

22 was in effect on or before the date the claimed in23 vention was made; 

24 ‘‘(B) the claimed invention was made as a re25 sult of activities undertaken within the scope of the 

26 joint research agreement; and 
3

•HR 2391 EH 

1 ‘‘(C) the application for patent for the claimed 

2 invention discloses or is amended to disclose the 

3 names of the parties to the joint research agree4 ment. 

5 ‘‘(3) For purposes of paragraph (2), the term ‘joint 

6 research agreement’ means a written contract, grant, or 

7 cooperative agreement entered into by two or more per8 sons or entities for the performance of experimental, devel9 opmental, or research work in the field of the claimed in10 vention.’’. 

11 SEC. 3. EFFECTIVE DATE. 

12 (a) IN GENERAL.—The amendments made by this 

13 Act shall apply to any patent granted on or after the date 

14 of the enactment of this Act. 

15 (b) SPECIAL RULE.—The amendments made by this 

16 Act shall not affect any final decision of a court or the 

17 United States Patent and Trademark Office rendered be18 fore the date of the enactment of this Act, and shall not 

19 affect the right of any party in any action pending before 

20 the United States Patent and Trademark Office or a court 

21 on the date of the enactment of this Act to have that par22 ty’s rights determined on the basis of the provisions of 
4

•HR 2391 EH 

1 title 35, United States Code, in effect on the day before 

2 the date of the enactment of this Act.

Passed the House of Representatives March 10, 

2004. 

Attest:

Clerk.
#### § 1500.21 United States.

*United States* means the several States and the District of Columbia.
### §1903. Amount of insurance

Insurance shall be issued in any multiple of $500 and the amount of insurance with respect to any one person shall be not less than $1,000 or more than $10,000. No person may carry a combined amount of National Service Life Insurance and United States Government life insurance in excess of $10,000 at any one time. The limitations of this section shall not apply to the additional paid up insurance the purchase of which is authorized under section 1907 of this title.

(Pub. L. 85–857, Sept. 2, 1958, 72 Stat. 1148, §703; Pub. L. 92–188, §1, Dec. 15, 1971, 85 Stat. 645; renumbered §1903 and amended Pub. L. 102–83, §5(a), (c)(1), Aug. 6, 1991, 105 Stat. 406.)

#### **Editorial Notes**

#### Prior Provisions

Prior section 1903 was renumbered section 3903 of this title.

Another prior section 1903, Pub. L. 85–857, Sept. 2, 1958, 72 Stat. 1216, related to limitation on amounts paid by United States, prior to the general revision of chapter 39 of this title by Pub. L. 91–666. See section 3902 of this title.

#### Amendments

1991—Pub. L. 102–83 renumbered section 703 of this title as this section and substituted "1907" for "707".

1971—Pub. L. 92–188 made section limitations inapplicable to the additional paid up insurance purchase of which is authorized under section 707 of this title.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 1971 Amendment

Amendment by Pub. L. 92–188 effective on date established by Administrator but in no event later than first day of first calendar month beginning more than six calendar months after Dec. 15, 1971, see section 4 of Pub. L. 92–188, set out as a note under section 1907 of this title.
---

EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICERPURSUANT TO
  18 U.S.C. SECTION 1350, 
  AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Invision Capital,
  Inc. (the “Company”) on Form 10-QSB for the quarter ended April
  30, 2005, as filed with the Securities and Exchange Commission on the date hereof
  (the “Periodic Report”), I, Frank J. Rigney, Chief Executive Officer
  of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
  to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|1. | the Periodic Report fully complies with the requirements
        of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                       
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|  
|2. | the information contained in the Periodic Report
        fairly presents, in all material respects, the financial condition and
        results of operations of the Company.

Dated: May 27, 2005

/s/ “Frank J. Rigney”

Frank J. Rigney
  Chief Executive Officer

---